Clinically, the expression of heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1) and PKM2 has been reported to be upregulated in patients with sorafenib-resistant HCC and is inversely correlated with the expression level of miR-374b [175]. Here, HNRNPA1 is linked to hepatocellular carcinoma.